Copyright
©The Author(s) 2024.
World J Gastroenterol. Jul 21, 2024; 30(27): 3290-3303
Published online Jul 21, 2024. doi: 10.3748/wjg.v30.i27.3290
Published online Jul 21, 2024. doi: 10.3748/wjg.v30.i27.3290
Figure 8 Effects of fatty acids on metabolic-associated fatty liver disease.
Through serum targeted metabolomics studies, we measured four specific biomarkers. The preliminary conclusion was that the transformation of lean control individuals to lean metabolic-associated fatty liver disease (MAFLD) may affect the Oleic acid, linoleic-arachidonic acid and palmitic acid pathways. Linoleic acid is converted to arachidonic acid by Δ-6 desaturase, as shown in the figure.
- Citation: Sun PQ, Dong WM, Yuan YF, Cao Q, Chen XY, Guo LL, Jiang YY. Targeted metabolomics study of fatty-acid metabolism in lean metabolic-associated fatty liver disease patients. World J Gastroenterol 2024; 30(27): 3290-3303
- URL: https://www.wjgnet.com/1007-9327/full/v30/i27/3290.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i27.3290